(Q44415276)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12712452%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Role of proliferation in HER2 status predicted response to doxorubicin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12712452%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12712452%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Giovanni Luca Beretta

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12712452%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Andrea Balsari

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12712452%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

Manuela Campiglio

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12712452%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Giulia Somenzi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12712452%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Clelia Olgiati

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12712452%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Pinuccia Valagussa

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12712452%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Sylvie Ménard

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12712452%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

English

0 references

publication date

1 July 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12712452%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Cancer

3 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12712452%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

105

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12712452%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12712452%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

568-573

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12712452%20AND%20SRC:MED&resulttype=core&format=json

A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin

3 November 2019

cites work

1 reference

The effect of HER-2/neu overexpression on chemotherapeutic drug sensitivity in human breast and ovarian cancer cells

21 January 2018

1 reference

HER-2/neu as a predictive marker of response to breast cancer therapy

21 January 2018

1 reference

Amplification and deletion of topoisomerase IIalpha associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer

21 January 2018

1 reference

Ectopic expression of inactive forms of yeast DNA topoisomerase II confers resistance to the anti-tumour drug, etoposide

21 January 2018

1 reference

Selection of a subpopulation with fewer DNA topoisomerase II alpha gene copies in a doxorubicin-resistant cell line panel

21 January 2018

1 reference

Relationship between expression of topoisomerase II isoforms and intrinsic sensitivity to topoisomerase II inhibitors in breast cancer cell lines

21 January 2018

1 reference

Predictive value of topoisomerase IIalpha and other prognostic factors for epirubicin chemotherapy in advanced breast cancer

21 January 2018

1 reference

Increased expression of c-erbB-2 in hormone-dependent breast cancer cells inhibits cell growth and induces differentiation.

21 January 2018

1 reference

p185 HER2/neu epitope mapping with murine monoclonal antibodies

21 January 2018

1 reference

HER-2 and choice of adjuvant chemotherapy in breast cancer

21 January 2018

1 reference

HER2 overexpression and doxorubicin in adjuvant chemotherapy for resectable breast cancer.

21 January 2018

1 reference

When is a tumor marker ready for prime time? A case study of c-erbB-2 as a predictive factor in breast cancer

21 January 2018

1 reference

Role of HER2 gene overexpression in breast carcinoma

21 January 2018

1 reference